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Esophageal Baseline Impedance From High-resolution
Impedance Manometry Correlates With Mean
Nocturnal Baseline Impedance From
pH-impedance Monitoring
Anthony Horton,1 Brian Sullivan,1,2 Katie Charles,1 Thasha McIntosh,2 Andrea Davis,2 Ziad Gellad,1,2 Rahul Shimpi,1
C Prakash Gyawali,3 and Amit Patel1,2*
1
Division of Gastroenterology, Duke University School of Medicine, Durham, NC, USA; 2Durham Veterans Affairs Medical Center, Durham, NC,
USA; and 3Division of Gastroenterology, Washington University School of Medicine, St Louis, MO, USA

Background/Aims
Esophageal baseline impedance (BI) can be extracted from pH-impedance tracings as mean nocturnal baseline impedance (MNBI), and
from high-resolution impedance manometry (HRIM), but it is unknown if values are similar between acquisition methods across HRIM
manufacturers. We aim to assess correlations between MNBI and BI from HRIM (BI-HRIM) from 2 HRIM manufacturers in the setting
of physiologic acid exposure time (AET).
Methods
HRIM and pH-impedance monitoring demonstrating physiologic AET (< 4%) off proton pump inhibitors were required. BI-HRIM was
extracted as the average from 5 cm and 10 cm above the lower esophageal sphincter. Distal BI-HRIM (DBI-HRIM) was also extracted
from the most distal channel (Medtronic studies). MNBI was extracted from 6 channels. Concordance between BI-HRIM across
manufacturers with MNBI was analyzed.
Results
Thirty-six patients met the inclusion criteria (59.6 ± 1.7 years; 22% female; body mass index 30.5 ± 0.7; AET 1.6 ± 0.2%). Although
MNBI was similar at all channels (P ≥ 0.18), Diversatek BI-HRIM was lower than Medtronic BI-HRIM (P = 0.003). Overall, BI-HRIM
correlated with MNBI at corresponding recording sites, 7 cm and 9 cm (P < 0.05), but not at other sites (P ≥ 0.19). Pearson’s
correlations > 0.5 were seen at MNBI at 7 cm for both systems, and at 9 cm for Medtronic. DBI-HRIM correlated with MNBI at 3 cm
and 5 cm (P < 0.03), but not at other locations (P > 0.1).
Conclusions
While numeric differences exist between manufacturers, BI-HRIM correlates with MNBI from corresponding channels in patients with
physiologic AET. Comparison with AET elevation is needed to determine correlations between pathologic MNBI with BI-HRIM across
manufacturers. The optimal HRIM channels from which BI values should be extracted also warrants further study.
(J Neurogastroenterol Motil 2020;26:455-462)
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Introduction

Materials and Methods

Ambulatory reflux monitoring is often utilized when symptoms
suspicious for gastroesophageal reflux disease (GERD) persist despite antisecretory therapy.1,2 Esophageal acid exposure time (AET)
and reflux-symptom association (RSA) from ambulatory reflux
monitoring can phenotype GERD and guide management.3-5
While AET from pH monitoring remains the most consistent
predictor of symptom outcome, combination with impedance monitoring increases RSA yield and enhances confidence in a reflux
mechanism for symptoms.4,6 However, catheter-based ambulatory
reflux monitoring provides only a cross-sectional assessment of
reflux burden and may not capture day-to-day variation in reflux
burden.7
In contrast, esophageal baseline impedance (BI) is a novel
marker for esophageal mucosal integrity, with lower values in erosive and non-erosive GERD compared to functional heartburn and
healthy controls.8,9 Extracted from the nocturnal phase of ambulatory pH-impedance tracings, mean nocturnal baseline impedance
(MNBI) can segregate reflux-related esophageal syndromes from
controls,10-12 and predicts symptom improvement from antireflux
therapy as a co-variate of distal AET.13,14 However, acquiring BI in
this fashion still requires cumbersome ambulatory catheter-based
monitoring and manual analysis of tracings.
High-resolution impedance manometry (HRIM), utilized to
identify the lower esophageal sphincter (LES) for appropriate positioning of pH-impedance catheters, also incorporates impedance
sensors to track esophageal bolus during pressure topography.15 BI
acquired during the landmark phase of HRIM (BI-HRIM) performed with Medtronic HRIM equipment has been demonstrated
to correlate with MNBI and reliably segregate patients with moderately pathologic AET from controls.16
Despite growing evidence supporting the value of BI from
both pH-impedance monitoring and HRIM in identifying refluxrelated esophageal syndromes, there is a paucity of similar data
in patients with physiologic AET and functional esophageal syndromes. Evaluation of BI-HRIM has only been conducted using
HRIM catheters from a single manufacturer (Medtronic, Minneapolis, MN, USA). In this study, we investigated BI-HRIM
and MNBI values among patients with physiologic AET, across 2
HRIM device manufacturers to assess BI relationships with esophageal symptoms, and to determine if BI values are similar between
HRIM devices in functional esophageal syndromes.
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Patients
Adults with persistent esophageal symptoms who underwent
esophageal HRIM using 1 of 2 device manufacturers (Diversatek,
Highlands Ranch, CO, USA; and Medtronic, Minneapolis, MN,
USA) and combined pH-impedance monitoring (Diversatek) at
the performing institution over a 2-year period were eligible for
inclusion into this retrospective observational cohort study. Exclusion criteria consisted of studies performed on antisecretory therapy,
distal esophageal AET > 4%, achalasia, previous foregut surgery,
inadequate studies (poor data quality precluding analysis), or incomplete studies (< 14 hours of recording time); patients with
esophageal body motor disorders without outflow obstruction were
not excluded. This study protocol was approved by the Institutional
Review Board at the performing institution (IRB No. 02083); a
waiver of informed consent was granted by the Institutional Review
Board.

High-resolution Impedance Manometry Baseline
Impedance
HRIM from 1 of 2 manufacturers (Diversatek and Medtronic) was used to localize the LES, identify motility disorders per Chicago classification version 3.0,17 and determine BI from esophageal
manometry (BI-HRIM). BI-HRIM was extracted from HRIM
studies as the average of impedance values from 5 cm and 10 cm
above the LES during quiet rest (“landmark phase”) prior to initiation of water swallows.18 Distal BI-HRIM (DBI-HRIM) was also
extracted from the distal-most esophageal impedance channel from
Medtronic HRIM studies.

pH-impedance Monitoring
Patients were instructed to stop their proton pump inhibitor
(PPI) medications for 7 days prior to the study, and any histamine-2 receptor antagonists, prokinetic medications, and antacids
3 days prior to the study. After an overnight fast, an experienced
nurse positioned the pH-impedance catheter (Diversatek) such that
the esophageal pH sensor was 5 cm proximal to manometrically-localized LES. Throughout the monitoring interval, patients logged
their meals, position (supine vs upright), and symptom events by
pressing appropriate buttons on the data recorder. Data uploaded
from pH-impedance studies were analyzed with dedicated software
(Bioview Analysis; Diversatek), with calculation of AET, reflux
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events, symptom events, and RSA parameters. AET was calculated
as the percentage of time the pH was below 4 at the distal esophageal pH sensor. AET < 4% was considered physiologic,19 and was
an entry criterion for this study.
Symptom events were considered associated with reflux episodes if they occurred within 2 minutes of a reflux episode. Symptom index was calculated as the ratio of symptom events associated
with reflux episodes to total symptom events and considered positive if > 50%.20 Symptom association probability was calculated
using the Ghillebert probability estimate,21 and designated positive
if > 95%, corresponding to P < 0.05.
pH-impedance tracings were interrogated by one of the authors (A.H.) in a blinded fashion to calculate MNBI values. BI
values were extracted at each impedance channel (3, 5, 7, 9, 15, and
17 cm above the LES) across stable nocturnal 10-minute periods
(at or around 1 AM, 2 AM, and 3 AM) to avoid reflux events or
swallows.22 The values from the 3 time periods for each channel
were averaged to yield the MNBI for each channel. Distal MNBI
was calculated as the average of MNBI values from the channels
located at 3, 5, 7, and 9 cm above the LES.13

Symptom Assessment
Prior to esophageal function testing at the performing institution, all patients completed symptom surveys to rate their dominant
and secondary symptom frequency and severity on 5-point Likert
scales, as well as esophageal global symptom severity (GSS) on 100mm visual analog scales, as previously described.4,5,23,24 Patients
rate symptom frequency from 0 (no symptoms) to 4 (multiple daily
episodes), and symptom severity from 0 (no symptoms) to 4 (very
severe symptoms). Dominant symptom intensity (DSI) is then calculated as the product of symptom frequency and symptom severity
(for a total score from 0 to 16). The DSI and GSS represented
symptom burden metrics for this study. Dominant symptoms were
also stratified into perceptive (heartburn and chest pain) and nonperceptive symptom groups.

Statistical Methods
Data are reported here as mean ± standard error of the mean,
unless otherwise indicated. Categorical data were compared using the χ-squared test, and continuous data were compared using
ANOVA or the 2-tailed Student’s t test, as appropriate. Correlations

Table 1. Comparisons Between High-resolution Impedance Manometry Systems

Clinical characteristics

All HRIM
(N = 36)

Diversatek HRIM
(n = 14)

Medtronic HRIM
(n = 22)

P -valuea

Age (yr)
Gender (female)
BMI
Perceptive dominant symptom
GSS
DSI
Normal esophageal body motility on HRM
Total AET (%)
BI-HRIM
MNBI-17
MNBI-15
MNBI-9
MNBI-7
MNBI-5
MNBI-3
Distal MNBIb

59.6 ± 1.7
8 (22%)
30.5 ± 0.7
27 (75%)
69.0 ± 4.5
10.4 ± 1.0
25 (69%)
1.6 ± 0.2
1564 ± 140
2184 ± 150
2083 ± 149
1553 ± 121
1589 ± 148
1474 ± 152
1376 ± 139
1498 ± 124

62.0 ± 2.2
3 (21%)
29.9 ± 1.1
11 (79%)
62.9 ± 6.5
8.7 ± 1.7
10 (71%)
1.2 ± 0.3
1062 ± 124
2387 ± 260
2151 ± 230
1703 ± 168
1699 ± 226
1713 ± 269
1614 ± 274
1683 ± 204

58.1 ± 2.4
5 (23%)
30.9 ± 0.9
16 (73%)
72.9 ± 6.0
11.4 ± 1.2
15 (68%)
1.8 ± 0.3
1884 ± 186
2055 ± 180
2039 ± 199
1458 ± 167
1519 ± 198
1322 ± 177
1225 ± 142
1381 ± 154

0.259
0.927
0.473
0.693
0.279
0.180
0.837
0.247
0.003
0.285
0.719
0.332
0.561
0.214
0.175
0.241

a

Comparison between Diversatek and Medtronic high-resolution impedance manometry (HRIM) systems (performed with independent-samples
t tests or Chi-square, as appropriate).
b
Distal mean nocturnal baseline impedance (MNBI) represents the averaged MNBI values for 3,5,7, and 9 cm above the lower esophageal sphincter (LES).
BMI, body mass index; GSS, global symptom severity; DSI, dominant symptom intensity; HRM, high-resolution manometry; AET, acid exposure time; BI-HRIM, baseline impedance from HRIM.
Vol. 26, No. 4 October, 2020 (455-462)
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between continuous variables (BI-HRIM, MNBI, and symptom
burden) were quantified using Pearson’s correlation coefficient. In
all cases, P < 0.05 was required for statistical significance. Statistical analyses were performed using IBM SPSS Statistics version 23
(Armonk, NY, USA).

Results
Study Cohorts
Inclusion criteria were met by 36 patients (age 59.6 ± 1.7 years,
22% female, body mass index 30.5 ± 0.7), with a mean total AET
of 1.6 ± 0.2% (Table 1). Dominant perceptive symptoms were
reported by 75% of the cohort, and symptom burden was modestly
high (GSS 69.0 ± 4.5, DSI 10.4 ± 1.0). Esophageal body motor
function was normal in 25 patients (69%); of the remainder, 5 had
ineffective esophageal motility, 4 had jackhammer esophagus, and 1

each had absent contractility and diffuse esophageal spasm. HRIM
was performed using Diversatek catheters in 14 (39%), and the
remainder using Medtronic catheters. Demographics (age, gender,
and body mass index), proportions with dominant perceptive symptoms, symptom burden metrics, proportions with normal esophageal body motor function on HRM, and total AET were similar
between HRIM manufacturer cohorts (P ≥ 0.180; Table 1).

Mean Nocturnal Baseline Impedance and Baseline
Impedance From High-resolution Impedance
Manometry Values
Those with abnormal esophageal body motor function on
HRM had similar BI-HRIM and MNBI values to those with
normal body motor function (P > 0.369). Individual MNBI values at each impedance site as well as composite distal MNBI were
similar between the 2 HRIM manufacturer cohorts (P ≥ 0.175;
Table 1). In contrast, BI-HRIM acquired from Diversatek cath-

Table 2. Pearson Correlations With Baseline Impedance From High-resolution Impedance Manometry

MNBI, cm above the LES

Total cohort (N = 36)

Diversatek (n = 14)

Medtronic (n = 22)

MNBI-17
MNBI-15
MNBI-9
MNBI-7
MNBI-5
MNBI-3
Distal MNBIa

–0.10 (P = 0.564)
0.08 (P = 0.663)
0.33 (P = 0.047)
0.40 (P = 0.015)
0.22 (P = 0.190)
0.17 (P = 0.314)
0.32 (P = 0.058)

–0.04 (P = 0.885)
–0.07 (P = 0.806)
0.22 (P = 0.451)
0.51 (P = 0.064)
0.36 (P = 0.202)
0.26 (P = 0.379)
0.39 (P = 0.167)

–0.002 (P = 0.993)
0.18 (P = 0.413)
0.56 (P = 0.007)
0.54 (P = 0.010)
0.43 (P = 0.047)
0.44 (P = 0.040)
0.55 (P = 0.008)

a

Distal mean nocturnal baseline impedance (MNBI) represents the averaged MNBI values for 3,5,7, and 9 cm above the lower esophageal sphincter (LES).
Medtronic HRIM

Diversatek pH-impedance

0.002, P = 0.993 17 cm

0.04, P = 0.885

0.18, P = 0.413 15 cm

0.07, P = 0.806

0.56, P = 0.007

9 cm

0.22, P = 0.451

0.54, P = 0.010

7 cm

0.51, P = 0.064

5 cm

0.43, P = 0.047

5 cm

3 cm

0.44, P = 0.040

3 cm

Diversatek HRIM

10 cm

10 cm

*

0.36, P = 0.202

Figure. Pearson correlations and corre-

5 cm

0.26, P = 0.379
*pH sensor at 5 cm
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sponding P -values for baseline impedance from high-resolution impedance
manometry (HRIM) by HRIM system
(Medtronic or Diversatek) with mean
nocturnal baseline impedance (MNBI)
calculated at each Diversatek pHimpedance channel.

Baseline Impedance on Manometry and pH-impedance

eters was significantly lower than that from Medtronic catheters
(1062 ± 124 Ω vs 1884 ± 186 Ω, P = 0.003), despite similar
symptom burden and AET in the 2 cohorts.

Correlations Between Mean Nocturnal Baseline
Impedance (MNBI) and Baseline Impedance From
High-resolution Impedance Manometry (BI-HRIM)
Across the total cohort, there were statistically significant correlations between BI-HRIM and MNBI at comparable channels––7 cm (r = 0.40, P = 0.015) and 9 cm (r = 0.33, P = 0.047)
proximal to the LES––but not at other sites (P ≥ 0.19; Table 2 and
Figure). Diversatek BI-HRIM numerically trended with MNBI
at 7 cm (r = 0.51, P = 0.064), but not at the other MNBI sites (P
≥ 0.202). Medtronic BI-HRIM correlated with MNBI at 3, 5,
7, and 9 cm above the LES (r ≥ 0.43 and P ≤ 0.047 for all sites),
but not at the proximal esophageal channels located at 15 cm and
17 cm above the LES (P ≥ 0.413).
DBI-HRIM from Medtronic catheters was also calculated
from the most distal esophageal impedance sensor (1471 ± 172
Ω). There were significant correlations between DBI-HRIM and
the closest corresponding MNBI values at 3 cm (r = 0.58, P =
0.005) and 5 cm (r = 0.48, P = 0.024; Table 3). However, these
correlations incrementally decreased as MNBI was acquired from
progressively proximal channels.

Table 3. Pearson Correlations With Medtronic Distal Baseline Im-

pedance From High-resolution Impedance Manometry

a

MNBI, cm above the LES

Medtronic DBI-HRIMa
(n = 22)

MNBI-17
MNBI-15
MNBI-9
MNBI-7
MNBI-5
MNBI-3
Distal MNBIb

0.03 (P = 0.883)
0.16 (P = 0.475)
0.24 (P = 0.288)
0.34 (P = 0.123)
0.48 (P = 0.024)
0.58 (P = 0.005)
0.44 (P = 0.038)

Distal baseline impedance from high-resolution impedance manometry (DBI-HRIM) represents the baseline impedance from highresolution impedance manometry (BI-HRIM) obtained from the
most distal esophageal impedance sensor using the Medtronic HRIM
catheter.
b
Distal mean nocturnal baseline impedance (MNBI) represents the
averaged MNBI values for 3,5,7, and 9 cm above the lower esophageal sphincter (LES).

Correlations Between Baseline Impedance and
Symptoms
Patients presenting with dominant perceptive symptoms had no
significant differences in distal composite MNBI values, compared to
those with dominant non-perceptive symptoms (perceptive: 1481 ±
125 Ω, non-perceptive: 1549 ± 341 Ω; P = 0.816). Further, there
were no differences in BI-HRIM values based on dominant perceptive versus non-perceptive symptoms (Diversatek: 992 ± 90 Ω
vs 1315 ± 530 Ω; P = 0.606; Medtronic: 1886 ± 217 Ω vs 1877
± 395 Ω; P = 0.983). Although GSS and DSI correlated with
each other (r = 0.65, P < 0.001), neither symptom burden metric
correlated with distal composite MNBI (r < 0.05, P > 0.785),
Medtronic BI-HRIM (r < 0.38, P > 0.081), or Diversatek BIHRIM (r < 0.40, P > 0.158).

Discussion
In this study, we demonstrate that BI acquired from HRIM
studies correlates with corresponding MNBI acquired from 24hour pH-impedance tracings in patients with physiologic AET
tested off antisecretory therapy, with numerical differences noted
between HRIM manufacturers. Although they shared similar
MNBI values across all channels, BI-HRIM acquired from Diversatek catheters was significantly lower than that from Medtronic
catheters. Further, BI-HRIM from Medtronic catheters correlated
with MNBI across more measurement sites in the distal esophagus,
with stronger Pearson correlation values, compared to Diversatek
catheters. There were no apparent differences in MNBI or BIHRIM in patients presenting with dominant perceptive versus
non-perceptive symptoms. Finally, no significant associations were
noted between symptom burden metrics and BI values, regardless
of method of acquisition or manufacturer.
Ambulatory pH-impedance monitoring, which combines
esophageal pH monitoring with impedance sensors to define reflux
events regardless of acidity, aids in the diagnosis and phenotyping
of GERD.19,25,26 Recently, interest in impedance monitoring has
focused on assessing esophageal mucosal integrity using baseline or
mucosal impedance analysis.12 Specifically, esophageal acid exposure
in both animals and humans induces changes in the mucosal integrity of the esophagus, as seen histologically by increased numbers of
dilated intracellular spaces, which corresponds with lower mucosal
impedance values.8,9,27,28 BI values acquired from pH-impedance
tracings (MNBI) have been described to negatively correlate with
AET,9 predict symptomatic response with antireflux therapy,13 and
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improve with the healing of esophagitis.13,29,30 MNBI has also been
shown to distinguish non-erosive reflux disease (NERD) and reflux
hypersensitivity from functional heartburn and healthy controls.10-12
Compared to PPI-refractory NERD, PPI-responsive NERD is
associated with lower MNBI.11,22 Even when AET is borderline or
inconclusive, MNBI values correlate with symptomatic outcome
with antireflux therapy.14
Since HRIM catheters incorporate technology to measure
esophageal impedance,15 BI-HRIM has potential to provide BI
data without subjecting patients to ambulatory transnasal catheterbased monitoring. We demonstrate that there are differences
between BI recorded from the 2 manufacturers studied, and
thresholds defined for one manufacturer may not apply to the other.
Recent work from the Mayo group demonstrated that BI acquired
from Medtronic HRIM studies correlated with MNBI (r = 0.59),
and segregated patients with pathologic AET ≥ 5% from controls
(AET ≤ 3%), with a threshold of 1582 Ω having a sensitivity of
86.2% and specificity of 88.5% for GERD.16 While this proposed
cutoff for BI-HRIM applies for Medtronic HRIM catheters, this
may not be applicable for Diversatek HRIM catheters.
The HRIM catheters differ in sensor morphology between
these manufacturers––the Diversatek pressure sensors protrude
from the catheter, while the Medtronic pressure sensors are more
embedded along the catheter. Prior work has demonstrated variability in HRM software metrics (including integrated relaxation
pressures) between solid-state manometry systems,31-35 and the Chicago classification therefore acknowledges differences in threshold
values for HRM metrics based on manometry systems (particularly
for integrated relaxation pressures).17 Although these differences in
solid-state manometry pressure sensors and metrics are established,
similar investigations into potential differences in impedance sensing between manometry systems have not been performed, to our
knowledge.
Moreover, correlations between MNBI and BI-HRIM differed between Medtronic and Diversatek catheters. However, the
optimal HRIM channels from which to extract BI values needs
further investigation. Further, impedance values can be influenced
by the presence of fluid in the esophageal lumen, and the absence
of liquid content within the esophageal lumen cannot be completely
excluded during a 10-15 minutes HRIM study, especially if there
is concurrent esophageal hypomotility.36
Limitations in our study design temper our conclusions. This
was a retrospective cohort study; patients were not randomized to
undergo HRIM with a particular catheter manufacturer (or both,
to serve as internal controls). Optimally, sequential studies with
460

HRIM catheters from both manufacturers would have provided
better comparison. Further, the strict parameters for study inclusion
resulted in relatively small cohort sizes that could have resulted in
insufficient power to detect potential differences. This study was
performed at a tertiary care center among a population of veterans,
with a skewed population of more male and older patients than most
published esophageal motility cohorts, and thus generalizability to
community gastroenterology practices may be limited. However,
we believe that better understanding esophageal symptoms and
disorders in this sometimes-overlooked population is an important
consideration. Finally, treatment approaches and symptom outcome
data were unavailable for the cohort.
In summary, we report that BI-HRIM correlates with MNBI
extracted from corresponding impedance channels in patients with
physiologic esophageal acid burden on testing off antisecretory
therapy. Our study is unique in assessment of BI-HRIM between
2 different HRIM manufacturers, demonstrating numeric differences in BI-HRIM based on HRIM manufacturer. Further work
is needed to determine the optimal HRIM channels from which
to extract BI for maximal clinical value, and comparison in patients
with corresponding AET elevation is warranted to better understand the associations between MNBI, BI-HRIM, and esophageal
acid exposure.
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